Albumin-bound paclitaxel, ABI-007 may show better efficacy than paclitaxel in basal-like breast cancers: Association between caveolin-1 expression and ABI-007

Breast Cancer Research and Treatment

Volumn 100, Issue 3, 2006, Pages 329-330

  Altundag, Kadri ^a   Bulut, Nilufer ^a   Dizdar, Omer ^a   Harputluoglu, Hakan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALCOHOL; CASTOR OIL; CAVEOLIN 1; DOCETAXEL; DOXORUBICIN; PACLITAXEL; POLYSORBATE 80; TAXANE DERIVATIVE;

BREAST CANCER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TRANSPORT; FAMILIAL CANCER; HUMAN; HYPERSENSITIVITY REACTION; LETTER; ONCOGENE; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALBUMINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA; CAVEOLIN 1; FEMALE; HUMANS; PACLITAXEL; PATIENT SELECTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 33750685309     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9250-8     Document Type: Letter

References (6)

1. Pinilla SM, Honrado E, Hardisson D, Benitez J, Palacios J (2006) Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat Mar 16; [Epub ahead of print]
2. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678-5685
3. Taxol (paclitaxel) Injection: Package Insert. Princeton, NJ, Bristol-Myers Squibb Co, 2003
4. Taxotere (docetaxel) Injection Concentrate: Package Insert. Bridgewater, NJ, Aventis Pharmaceutical Products, Inc, April 2003
5. Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J (2005) Superior efficacy of albumin-bound paclitaxel, ABI-007, compared with polyethylated castor oil-based paclitaxel in women with metastatic breast cancer: results of a phase III trial. J Clin Oncol 23:7794-7803
6. Desai N, Yao Z, Trieu V, Soon-Shiong P, Dykes D, Noker P (2003) Evidence of greater antitumor activity of Cremophor-free nanoparticle albumin-bound (nab) paclitaxel (Abraxane) compared to Taxol: role of a novel albumin transporter mechanism. Presented at the 26th annual San Antonio breast cancer symposium, San Antonio, TX, December 3-6, 2003